Price Capital Management’s Biogen BIIB Stock Holding History

Price Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-586	Closed	-$247K	–	26
2015 Q1	$247K	Buy	+586	New	+$231K	0.15%	143

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Price Capital Management's BIIB Position: Q2 2015 in Review

Price Capital Management sold out of Biogen (BIIB) in Q2 2015, closing a stake of 586 shares — an estimated $247K sold.

Price Capital Management first reported a position in BIIB in Q1 2015 and held it in 1 quarter. The position peaked at $247K in Q1 2015. 974 funds tracked by Wall St. Rank hold BIIB as of Q2 2015.

Price Capital Management reported no remaining Biogen position as of Q2 2015 after selling out during the quarter.
Price Capital Management sold 586 Biogen shares in Q2 2015, an estimated $247K.
Price Capital Management first reported a position in Biogen in Q1 2015 and held it in 1 quarter.
Price Capital Management's Biogen position peaked at $247K in Q1 2015.
974 funds tracked by Wall St. Rank held Biogen as of Q2 2015.

Based on Price Capital Management's 13F filing for Q2 2015.